Autoinflammation with infantile enterocolitis is a rare genetic condition that begins very early in life, causing severe inflammation throughout the body and serious intestinal problems in infants. The disease follows a pattern where babies struggle with gut inflammation that often improves over time, but periodic fever episodes and other inflammatory flares continue into later life.
Epidemiology
Autoinflammation with infantile enterocolitis, also known by its abbreviated name AIFEC, is an extremely rare condition. According to available medical data, the disease occurs in fewer than one person per million individuals worldwide, making it one of the rarest genetic inflammatory conditions known to medicine.[5][9] Because the condition was only identified and described in medical literature beginning in 2014, the true number of affected individuals globally remains uncertain, and many cases may still go undiagnosed or misdiagnosed as other conditions.
The condition affects both males and females equally, which is consistent with its pattern of inheritance. Early medical reports documented the disease in at least two unrelated families, including a father and his two sons, demonstrating that the condition can appear in multiple generations within the same family.[2][4] As awareness of this condition grows among healthcare providers and genetic testing becomes more widely available, additional cases continue to be identified around the world, suggesting that the actual prevalence may be higher than currently recognized.
The disease begins in the neonatal period or very early infancy, meaning symptoms appear within the first weeks or months after birth.[5][9] This very early onset distinguishes autoinflammation with infantile enterocolitis from many other inflammatory conditions that typically appear later in childhood or adulthood. The severity of symptoms in infancy can vary considerably between affected individuals, even within the same family, with some babies experiencing life-threatening complications while others have milder presentations.
Causes
Autoinflammation with infantile enterocolitis is caused by mutations, or changes, in a specific gene called NLRC4, which is located on chromosome 2 at position 2p22.3.[1][3] This gene contains the instructions for making a protein that plays an important role in the body’s immune system, specifically in detecting threats and triggering inflammatory responses when needed. In healthy individuals, the NLRC4 protein acts as a sensor that helps the immune system identify dangerous bacteria that have invaded cells.
The mutations that cause this disease are called “gain-of-function” mutations, which means they make the NLRC4 protein work too much rather than not enough. When the gene is mutated, the protein becomes overactive and triggers inflammation even when there is no real threat present.[2][4] This inappropriate activation leads to excessive production of inflammatory substances in the body, particularly proteins called cytokines that normally help coordinate immune responses but cause damage when present at very high levels.
The NLRC4 protein is part of a larger structure called an inflammasome, which functions like an alarm system inside cells. When this alarm system is constantly triggered due to the gene mutation, it releases powerful inflammatory signals including interleukin-18 (IL-18) and interleukin-1 beta (IL-1β).[2][10] These molecules cause widespread inflammation throughout the body, affecting multiple organs and systems, particularly the intestines in young infants.
Importantly, this is not an infectious disease and cannot be spread from one person to another. The condition results entirely from the genetic mutation present in an individual’s DNA from conception. Some cases have been identified where the mutation occurred as a new change in the affected person rather than being inherited from a parent, a phenomenon called somatic mosaicism, where only some of the body’s cells carry the mutation rather than all of them.[13]
Risk Factors
The primary risk factor for developing autoinflammation with infantile enterocolitis is having a parent who carries the mutated NLRC4 gene. The condition follows an autosomal dominant pattern of inheritance, which means that only one copy of the altered gene is sufficient to cause the disease.[1][3] When one parent has the condition or carries the mutation, each child has a 50 percent chance of inheriting the mutated gene and potentially developing the disease. This pattern affects males and females equally, as the gene is located on one of the regular chromosomes rather than on the sex chromosomes.
Because the mutation provides the NLRC4 protein with excessive activity, even individuals with one normal copy and one mutated copy of the gene will develop symptoms. The severity of symptoms can vary considerably even among family members who share the same mutation, suggesting that other genetic or environmental factors may influence how the disease manifests in each person.
For babies and children who have inherited the mutation, certain triggers can provoke or worsen inflammatory flares. Viral infections represent one of the most common triggers, as the body’s immune response to infection can amplify the already excessive inflammatory signaling.[4][10] Physical stress, including overexertion or extreme fatigue, can also precipitate episodes of severe inflammation. Even emotional stress and anxiety have been identified as potential triggers for inflammatory flares in some affected individuals.
It is important to note that in some documented cases, the genetic mutation occurred spontaneously in the affected individual without being inherited from either parent. This means that even families with no history of the condition can have a child with autoinflammation with infantile enterocolitis. Once such a mutation occurs, the affected person can then potentially pass it to their own children.
Symptoms
The symptoms of autoinflammation with infantile enterocolitis typically begin during the first week or month of life, making it a condition that presents very early in infancy. The initial symptoms usually center on severe intestinal inflammation, medically termed enterocolitis, which causes significant distress and health problems for affected newborns. Babies with this condition commonly develop severe, watery diarrhea that is described as secretory in nature, meaning the intestines are actively secreting fluid rather than simply failing to absorb it properly.[2][4]
Alongside the diarrhea, affected infants frequently experience repeated episodes of vomiting, making it difficult for them to keep down food and fluids. This combination of symptoms leads to one of the most concerning features of the disease: failure to thrive. Babies with autoinflammation with infantile enterocolitis struggle to gain weight appropriately and often show poor overall growth compared to other infants their age.[2][4] This growth failure occurs both because the inflamed intestines cannot properly absorb nutrients and because the body is expending enormous amounts of energy fighting the constant inflammation.
Fever is another hallmark symptom of this condition. Affected babies experience periodic fevers, meaning the temperature elevations come and go in episodes rather than being constant.[4][10] These fevers can be quite high and are typically accompanied by other signs that the body is mounting a strong inflammatory response. The spleen, an organ involved in immune function, often becomes enlarged during these episodes, a condition called splenomegaly. Parents or doctors may be able to feel this enlargement when examining the baby’s abdomen.
As children grow older, many experience changes in their symptom pattern. Interestingly, the intestinal inflammation that dominates infancy tends to improve or even resolve with age.[4][10] However, the periodic fevers continue, often triggered by infections, physical exertion, or stress. During these fever episodes, older children and adults may develop joint pain, known as arthralgia, which can affect multiple joints and cause significant discomfort. Similarly, muscle pain or myalgia frequently accompanies the inflammatory flares.
Skin manifestations also occur in many affected individuals. Rashes that resemble hives or urticaria may appear during inflammatory episodes, adding to the patient’s discomfort.[5][9] These rashes typically resolve once the flare subsides but can recur with subsequent episodes.
In severe cases, particularly during the most intense inflammatory flares, affected individuals can develop life-threatening complications. Some patients experience episodes of blood cell abnormalities, including pancytopenia, where all three types of blood cells (red blood cells, white blood cells, and platelets) drop to dangerously low levels.[2][4] This can lead to problems with blood clotting, a condition called disseminated intravascular coagulation, which represents a medical emergency. In the most tragic cases, severe flares can progress to organ failure and death if not treated promptly and aggressively.
Prevention
Because autoinflammation with infantile enterocolitis is a genetic condition caused by mutations present from conception, there is currently no way to prevent the disease from developing in individuals who inherit or spontaneously acquire the NLRC4 mutation. However, families with a known history of the condition can take important steps to prepare for and potentially minimize the impact of the disease on future children.
Genetic counseling represents a crucial preventive strategy for families affected by this condition. Individuals who have autoinflammation with infantile enterocolitis or who know they carry the NLRC4 mutation can meet with genetic counselors before planning pregnancies to understand the 50 percent risk of passing the mutation to each child. These specialists can explain inheritance patterns, discuss reproductive options, and help families make informed decisions about family planning.
For families who know they are at risk, prenatal genetic testing may be available. Procedures such as amniocentesis or chorionic villus sampling can detect the NLRC4 mutation in a developing fetus during pregnancy, allowing parents to prepare for specialized medical care immediately after birth if needed. While these tests carry small risks to the pregnancy, they can provide valuable information that enables doctors to have treatment plans ready from the moment the baby is born, potentially preventing some of the most severe complications.
For individuals already diagnosed with the condition, secondary prevention focuses on avoiding or minimizing triggers that can provoke inflammatory flares. Since viral infections are known triggers, maintaining good hygiene practices, staying current with recommended vaccinations, and seeking prompt medical attention for infections can help reduce the frequency and severity of episodes.[4][10] Similarly, managing stress levels, avoiding overexertion, and ensuring adequate rest may help prevent some flares, though this is not always possible, especially in young children.
Early diagnosis represents another form of prevention, specifically preventing severe complications and death. Babies who present with the characteristic symptoms of severe enterocolitis, fever, and failure to thrive in early infancy should receive prompt evaluation, including genetic testing if autoinflammation with infantile enterocolitis is suspected. When the diagnosis is made quickly, targeted treatments can be initiated before life-threatening complications develop, significantly improving outcomes.
Pathophysiology
The disease process in autoinflammation with infantile enterocolitis begins at the molecular level within cells throughout the body, particularly those of the immune system and the intestinal lining. The NLRC4 protein normally functions as part of the innate immune system, the body’s first line of defense against infection that responds immediately to threats without requiring prior exposure.[8][12] This protein forms part of a structure called an inflammasome, which acts like a molecular surveillance system within cells.
In healthy individuals, the NLRC4 inflammasome activates only when specific bacterial proteins are detected inside cells, particularly proteins associated with bacteria that can move using flagella or that inject toxins into cells through specialized secretion systems. When these bacterial signatures are detected, the inflammasome activates an enzyme called caspase-1, which then triggers a cascade of inflammatory responses. This includes the processing and release of powerful inflammatory cytokines, particularly IL-18 and IL-1β, and can lead to a form of programmed cell death called pyroptosis that helps eliminate infected cells.
In individuals with autoinflammation with infantile enterocolitis, the mutated NLRC4 protein does not require bacterial signals to activate. Instead, the mutations cause the protein to be in a constantly active or easily triggered state, leading to inappropriate inflammasome activation even in the absence of infection.[2][4] This results in excessive, uncontrolled production of inflammatory cytokines, particularly IL-18 and IL-1β, which circulate through the bloodstream and affect tissues throughout the body.
The gastrointestinal system is particularly vulnerable to this excessive inflammation during infancy. The intestinal lining undergoes rapid changes and development in the first months of life, and the overactive immune signaling severely disrupts this process. Microscopic examination of intestinal tissue from affected infants shows changes called villous blunting, where the finger-like projections that normally line the intestine and absorb nutrients become flattened and damaged.[4][10] This structural damage impairs the intestines’ ability to absorb water and nutrients, leading to the severe diarrhea and failure to thrive that characterize the early phase of the disease.
The excessive levels of IL-18 have particularly important effects throughout the body. This cytokine stimulates the production of interferon-gamma, another powerful inflammatory molecule, and activates certain immune cells called natural killer cells and T cells. In patients with this condition, laboratory tests often reveal dramatically elevated IL-18 levels, sometimes hundreds of times higher than normal, which can serve as a diagnostic marker for the disease.[4][10]
The periodic nature of severe flares in this condition may relate to additional stressors that further activate the already overactive inflammasome. Viral infections, for example, can provide additional inflammatory signals that push the system past a critical threshold, triggering episodes of even more severe inflammation. During these episodes, the excessive cytokine release can activate macrophages, large immune cells that normally help clear infections but in this disease begin consuming blood cells, leading to the dangerous drops in blood cell counts seen during severe flares.[5][9]
Interestingly, the intestinal symptoms tend to improve as children age, even though the genetic mutation remains unchanged. This age-related improvement may reflect the completion of intestinal development and maturation, or changes in the intestinal bacterial communities that occur as children transition from milk-based diets to solid foods. However, the systemic inflammatory episodes persist throughout life, suggesting that while the developing intestine is particularly vulnerable to NLRC4-driven inflammation, other tissues remain susceptible to damage during inflammatory flares regardless of age.
